Tag: translational science
-
Apriori Bio and A*STAR Infectious Diseases Labs Forge Strategic Partnership to Advance Next-Generation Influenza Vaccines
Strategic Partnership to Accelerate Next-Generation Influenza Vaccines Apriori Bio, a Flagship Pioneering company dedicated to developing prospective, variant-resilient vaccines, has announced a strategic collaboration with the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs. This partnership aims to accelerate the discovery and development of next-generation influenza vaccines capable of addressing evolving strains and…
-
Two Verspeeten Endowed Chairs Set to Transform Cancer Care in London
Overview: A transformative gift for cancer research In a landmark move to accelerate progress against cancer, the late Archie and Irene Verspeeten, through the London Health Sciences Foundation (LHSF), have donated $5 million. Matched by Western University, this funding establishes two endowed research chairs within the Schulich School of Medicine & Dentistry and the broader…
-
Promising Drug Candidates Could Restore Myelin in MS: K102 and K110 Lead the Way
Overview: A potential breakthrough in multiple sclerosis treatment Multiple sclerosis (MS) is a chronic autoimmune disease where the body’s immune system damages the myelin sheath that insulates nerve fibers. This disruption slows or blocks nerve signals, leading to symptoms such as numbness, vision loss, and paralysis. While existing therapies help reduce inflammation, there are no…